ArticleBMC oral health2026
Preliminary species-dependent growth responses of selected oral bacteria to e-cigarette Liquids and aerosol extracts: a single-species in vitro study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increased use of electronic cigarettes (e-cigarettes) has raised concern regarding their potential impact on oral health. E-liquids contain a complex mixture of chemical constituents that may influence the growth of selected oral bacterial species under controlled in vitro conditions. However, comparative data evaluating commercial flavour categories, labelled nicotine concentrations, aerosol extracts, and undiluted e-liquids across both cariogenic and commensal oral bacteria remain limited. This study aimed to provide a preliminary assessment of growth responses of selected oral bacteria representing cariogenic, acid-tolerant, early-colonising, and health-associated species to e-cigarette aerosol extracts and e-liquids with different commercial flavour labels and nicotine concentrations under controlled single-species conditions.
methodsIn this in vitro study, aerosol extracts derived from 18 e-liquids with varying commercial flavour labels and nicotine concentrations (0, 14, and 20-25 mg/mL) were tested against selected oral bacterial species. Two independent bacterial cultures were evaluated, with three analytical replicates per condition within each biological repeat. Single-species planktonic growth was monitored over 48 h, and area under the curve (AUC) values were calculated. Growth-inhibitory activity of aerosol extracts and undiluted e-liquids was evaluated using an agar disk diffusion assay. The pH of undiluted e-liquids was also assessed as a semi-quantitative screening measure.
resultsDescriptively, most AUC means at the product level were below the untreated growth control, with species-dependent magnitudes of change; the largest reduction was observed for Actinomyces naeslundii (A. naeslundii). No consistent pattern was observed across commercial flavour categories or labelled nicotine concentrations. In the separate Streptococcus mutans (S. mutans) direct-exposure experiment, mean AUCs were 72.5-82.5% lower than the untreated growth control, and undiluted e-liquids produced zones of growth inhibition in the agar diffusion assay, particularly in flavoured formulations. Approximate pH screening values ranged from 4.0 to 5.0.
conclusionsThese preliminary observations suggest species-dependent growth responses to e-cigarette aerosol extracts and marked growth inhibition by undiluted e-liquids under the tested conditions. Because biological replication was limited (n = 2) and the chemical composition and storage stability of the aerosol extracts were not analytically verified, the findings should be interpreted descriptively and require confirmation in larger, chemically characterised, clinically relevant biofilm models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.